Human Factors Studies to Assess the Usability of the Faricimab Prefilled Syringe
Mark R Barakat,1,2 Henry M Kwong Jr,2,3 Gelson Marcon,4 Olivia E O’Leary,4 Liliana P Paris,5 Petrick Schneider,4 Yannan Tang,5 Jordan M Graff2,6,7 1Retina Macula Institute of Arizona, Scottsdale, AZ, USA; 2Department of Ophthalmology, University of Arizona College of Medicine – Phoenix, Phoenix, AZ,...
Saved in:
Main Authors: | Barakat MR, Kwong Jr HM, Marcon G, O'Leary OE, Paris LP, Schneider P, Tang Y, Graff JM |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2025-02-01
|
Series: | Clinical Ophthalmology |
Subjects: | |
Online Access: | https://www.dovepress.com/human-factors-studies-to-assess-the-usability-of-the-faricimab-prefill-peer-reviewed-fulltext-article-OPTH |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dosing intervals in Comparison of one-year real-world outcomes between red (670 nm) subthreshold micropulse laser treatment and intravitreal aflibercept injection for treatment-naïve diabetic macular edema
by: Kai Ching Peter Leung, et al.
Published: (2025-02-01) -
How intravitreal anti-vascular endothelial growth factor initial dosing impacts patient outcomes in diabetic macular oedema
by: Rishi P. Singh, et al.
Published: (2024-12-01) -
Bedside bilateral sequential intravitreal anti-VEGF injections for retinopathy of prematurity
by: Priya Bajgai, et al.
Published: (2025-01-01) -
Analysis of the aqueous humor before and after the administration of faricimab in patients with nAMD
by: Ryo Nonogaki, et al.
Published: (2024-12-01) -
Changes in Aqueous Humor Cytokine Profile Following Intravitreal Brolucizumab Injection
by: Ruamviboonsuk V, et al.
Published: (2025-02-01)